|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
630280312 |
| 003 |
DE-627 |
| 005 |
20230905072516.0 |
| 007 |
tu |
| 008 |
100629s2011 xxu||||| 00| ||eng c |
| 010 |
|
|
|a 2010025527
|
| 020 |
|
|
|a 9781616689780
|c softcover
|9 978-1-61668-978-0
|
| 035 |
|
|
|a (DE-627)630280312
|
| 035 |
|
|
|a (DE-599)GBV630280312
|
| 035 |
|
|
|a (OCoLC)838036812
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|
| 050 |
|
0 |
|a RC685.V2
|
| 060 |
|
0 |
|a WG 260
|
| 082 |
0 |
|
|a 616.1/25061
|q LOC
|2 22
|
| 084 |
|
|
|a 15,3
|2 ssgn
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.85
|2 bkl
|
| 245 |
1 |
0 |
|a Drug-induced valvular heart disease
|c Steven Droogmans ...
|
| 264 |
|
1 |
|a New York
|b Nova Science Publ.
|c c 2011
|
| 300 |
|
|
|a X, 52 S.
|b Ill., graph. Darst.
|c 22 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
0 |
|
|a Cardiology research and clinical developments
|
| 500 |
|
|
|a Includes bibliographical references (p. [35]-48) and index
|
| 505 |
8 |
0 |
|a Pathophysiology of drug-induced valvular heart disease -- Morphological and echocardiographic characteristics -- Drugs associated with valvular heart disease -- Influence of drug dose, treatment duration, and risk factors -- Natural course of toxic valvulopathy -- Small animal models of drug-induced valvular heart disease -- Practical recommendations for the use of potential valvulopathic drugs.
|
| 650 |
|
0 |
|a Heart valves
|x Diseases
|
| 650 |
|
0 |
|a Drugs
|x Toxicology
|
| 650 |
|
2 |
|a Heart Valve Diseases
|x chemically induced
|
| 650 |
|
2 |
|a Heart Valve Diseases
|x physiopathology
|
| 650 |
|
2 |
|a Heart Valves
|x drug effects
|
| 650 |
|
2 |
|a Heart Valves
|x pathology
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4159668-7
|0 (DE-627)104664843
|0 (DE-576)209852062
|a Herzklappenfehler
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4003134-2
|0 (DE-627)106390570
|0 (DE-576)208850368
|a Arzneimittelnebenwirkung
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Droogmans, Steven
|4 oth
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/630280312.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
| 936 |
b |
k |
|a 44.85
|j Kardiologie
|j Angiologie
|0 (DE-627)106409417
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 616.1/25061
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 1191169529
|c 00
|f --%%--
|d 2910-0457
|e --%%--
|j --%%--
|y k
|z 05-04-11
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$029100457
|
